Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1807499

Cover Image

PUBLISHER: Polaris Market Research | PRODUCT CODE: 1807499

Japan Immunoassay Market Size, Share, Trends, Industry Analysis Report By Product (Reagents & Kits, Analyzers/Instruments), By Technology, By Specimen, By Application, By End Use - Market Forecast, 2025-2034

PUBLISHED:
PAGES: 129 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 4250
PDF (Multi User License)
USD 5250
PDF (Enterprise License)
USD 6250

Add to Cart

The japan immunology market size is expected to reach USD 2.61 billion by 2034, according to a new study by Polaris Market Research. The report "Japan Immunoassay Market Share, Size, Trends, Industry Analysis Report By Product (Reagents & Kits, Analyzers/Instruments), By Technology, By Specimen, By Application, By End Use; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Immunology is the scientific discipline that focuses on understanding the body's defense mechanisms against pathogens and abnormal cells through immune system responses. The Japan immunology market growth is driven by the growing adoption of targeted biologic therapies, which are transforming treatment paradigms for autoimmune and inflammatory conditions. These therapies offer greater precision and reduced side effects compared to conventional immunosuppressants, aligning with Japan's ongoing efforts to enhance patient outcomes through advanced and individualized care. Biologics continue to gain momentum, strengthening their role in modern immunology practices as the demand for more effective and disease-specific treatments rises.

The Japan immunoassay market growth is attributed to the integration of digital health technologies in immunological research and patient management. Tools such as electronic health records, artificial intelligence in diagnostics, and remote monitoring systems are streamlining clinical workflows and supporting data-driven decision-making. These digital advancements improve patient tracking and treatment adherence and also facilitate personalized therapy adjustments based on real-time immune response data. Therefore, as Japan's healthcare ecosystem increasingly adopts these technologies, the immunoassay market in Japan is expected to benefit from improved efficiency, better clinical insights, and more tailored treatment pathways.

Japan Immunoassay Market Report Highlights

In terms of product, the reagents & kits segment generated USD 1.01 billion in 2024 revenue, due to essential recurring use across clinical labs and research institutions.

Based on technology, the rapid test segment is projected to register a CAGR of 5.0%, reflecting Japan's healthcare shift toward point-of-care testing and preventive medicine solutions.

A few global key market players include FUJIFILM Wako Pure Chemical Corporation; Fujirebio (H.U. Group Holdings/Fujirebio Inc.); Hitachi, Ltd.; Kyowa Hakko Kirin (Kyowa Kirin Co., Ltd.); LSI Medience Corporation; Nihon Kohden Corporation; Nippon Kayaku Co., Ltd.; Shimadzu Corporation; Sysmex Corporation; and Tosoh Corporation (Tosoh Bioscience).

Polaris Market Research has segmented the Japan immunoassay market report on the basis of product, technology, specimen, application, and end use:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Reagents & Kits

ELISA Reagents & Kits

Rapid Test Reagents & Kits

Western Blot Reagents & Kits

ELISPOT Reagents & Kits

Other Reagents & Kits

Analyzers/Instruments

Open Ended Systems

Closed Ended Systems

Software & Services

By Technology Outlook (Revenue, USD Billion, 2020-2034)

Enzyme Immunoassays (EIA)

Chemiluminescence Immunoassays (CLIA)

Fluorescence Immunoassays (FIA)

Rapid Test

Radioimmunoassay (RIA)

Others

By Specimen Outlook (Revenue, USD Billion, 2020-2034)

Blood

Urine

Saliva

Others

By Application Outlook (Revenue, USD Billion, 2020-2034)

Infectious Disease Testing

Cardiology

Oncology

Endocrinology

Autoimmune Diseases

Therapeutic Drug Monitoring

Others

By End Use Outlook (Revenue, USD Billion, 2020-2034)

Hospitals

Laboratories

Others

Product Code: PM6160

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Retail and E-Commerce
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Japan Immunoassay Market Insights

  • 4.1. Japan Immunoassay Market - Material Snapshot
  • 4.2. Japan Immunoassay Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Prevalence of Chronic Diseases and Cancer
      • 4.2.1.2. Rising Innovations in Immunoassay Technology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory Challenges and Market Fragmentation
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Japan Immunoassay Market Material Trends
  • 4.6. Value Chain Analysis

5. Japan Immunoassay Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Japan Immunoassay Market, by Product, 2020-2034 (USD Billion)
  • 5.3. Reagents & Kits
    • 5.3.1. Japan Immunoassay Market, by Reagents & Kits, 2020-2034 (USD Billion)
    • 5.3.2. ELISA Reagents & Kits
      • 5.3.2.1. Japan Immunoassay Market, by ELISA Reagents & Kits, 2020-2034 (USD Billion)
    • 5.3.3. Rapid Test Reagents & Kits
      • 5.3.3.1. Japan Immunoassay Market, by Rapid Test Reagents & Kits, 2020-2034 (USD Billion)
    • 5.3.4. Western Blot Reagents & Kits
    • 5.3.5. Japan Immunoassay Market, by Western Blot Reagents & Kits, 2020-2034 (USD Billion)
    • 5.3.6. ELISPOT Reagents & Kits
      • 5.3.6.1. Japan Immunoassay Market, by ELISPOT Reagents & Kits, 2020-2034 (USD Billion)
    • 5.3.7. Other Reagents & Kits
      • 5.3.7.1. Japan Immunoassay Market, by Other Reagents & Kits, 2020-2034 (USD Billion)
  • 5.4. Analyzers/Instruments
    • 5.4.1. Japan Immunoassay Market, by Analyzers/ Instruments, 2020-2034 (USD Billion)
    • 5.4.2. Open Ended Systems
      • 5.4.2.1. Japan Immunoassay Market, by Open Ended Systems, 2020-2034 (USD Billion)
    • 5.4.3. Closed Ended Systems
      • 5.4.3.1. Japan Immunoassay Market, by Closed Ended Systems, 2020-2034 (USD Billion)
  • 5.5. Software & Services
    • 5.5.1. Japan Immunoassay Market, by Software & Services, 2020-2034 (USD Billion)

6. Japan Immunoassay Market, Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Japan Immunoassay Market, Technology, 2020-2034 (USD Billion)
  • 6.3. Enzyme Immunoassays (EIA)
    • 6.3.1. Japan Immunoassay Market, by Enzyme Immunoassays (EIA), 2020-2034 (USD Billion)
    • 6.3.2. Chemiluminescence Immunoassays (CLIA)
      • 6.3.2.1. Japan Immunoassay Market, by Chemiluminescence Immunoassays (CLIA), 2020-2034 (USD Billion)
    • 6.3.3. Fluorescence Immunoassays (FIA)
      • 6.3.3.1. Japan Immunoassay Market, by Fluorescence Immunoassays (FIA), 2020-2034 (USD Billion)
  • 6.4. Rapid Test
    • 6.4.1. Japan Immunoassay Market, by Rapid Test, 2020-2034 (USD Billion)
  • 6.5. Radioimmunoassay (RIA)
    • 6.5.1. Japan Immunoassay Market, by Radioimmunoassay (RIA), 2020-2034 (USD Billion)
  • 6.6. Others
    • 6.6.1. Japan Immunoassay Market, by Others, 2020-2034 (USD Billion)

7. Japan Immunoassay Market, by Specimen

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Japan Immunoassay Market, by Specimen, 2020-2034 (USD Billion)
  • 7.3. Blood
    • 7.3.1. Japan Immunoassay Market, by Blood, 2020-2034 (USD Billion)
  • 7.4. Urine
    • 7.4.1. Japan Immunoassay Market, by Urine, 2020-2034 (USD Billion)
  • 7.5. Saliva
    • 7.5.1. Japan Immunoassay Market, by Saliva, 2020-2034 (USD Billion)
  • 7.6. Others
    • 7.6.1. Japan Immunoassay Market, by Others, 2020-2034 (USD Billion)

8. Japan Immunoassay Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Japan Immunoassay Market, by Application, 2020-2034 (USD Billion)
  • 8.3. Infectious Disease Testing
    • 8.3.1. Japan Immunoassay Market, by Infectious Disease Testing, 2020-2034 (USD Billion)
  • 8.4. Cardiology
    • 8.4.1. Japan Immunoassay Market, by Cardiology, 2020-2034 (USD Billion)
  • 8.5. Oncology
    • 8.5.1. Japan Immunoassay Market, by Oncology, 2020-2034 (USD Billion)
  • 8.6. Endocrinology
    • 8.6.1. Japan Immunoassay Market, by Endocrinology, 2020-2034 (USD Billion)
  • 8.7. Autoimmune Diseases
    • 8.7.1. Japan Immunoassay Market, by Autoimmune Diseases, 2020-2034 (USD Billion)
  • 8.8. Therapeutic Drug Monitoring
    • 8.8.1. Japan Immunoassay Market, by Therapeutic Drug Monitoring, 2020-2034 (USD Billion)
  • 8.9. Others
    • 8.9.1. Japan Immunoassay Market, by Others, 2020-2034 (USD Billion)

9. Japan Immunoassay Market, by End Use

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Japan Immunoassay Market, by End Use, 2020-2034 (USD Billion)
  • 9.3. Hospitals
    • 9.3.1. Japan Immunoassay Market, by Hospitals, 2020-2034 (USD Billion)
  • 9.4. Laboratories
    • 9.4.1. Japan Immunoassay Market, by Laboratories, 2020-2034 (USD Billion)
  • 9.5. Others
    • 9.5.1. Japan Immunoassay Market, by Others, 2020-2034 (USD Billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. FUJIFILM Wako Pure Chemical Corporation
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Fujirebio (H.U. Group Holdings/Fujirebio Inc.)
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Hitachi, Ltd.
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Kyowa Hakko Kirin (Kyowa Kirin Co., Ltd.)
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. LSI Medience Corporation
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Nihon Kohden Corporation
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Nippon Kayaku Co., Ltd.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Shimadzu Corporation
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Sysmex Corporation
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. Tosoh Corporation (Tosoh Bioscience)
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
Product Code: PM6160

List of Tables:

  • Table 1 US: Japan Immunoassay Market, By Product, 2020-2034 (USD Billion)
  • Table 2 US: Japan Immunoassay Market, Technology, 2020-2034 (USD Billion)
  • Table 3 US: Japan Immunoassay Market, By Specimen, 2020-2034 (USD Billion)
  • Table 4 US: Japan Immunoassay Market, By Application, 2020-2034 (USD Billion)
  • Table 5 US: Japan Immunoassay Market, by End Use, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Japan Immunoassay Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Porter's Five Forces
  • Figure 5. Market By Product
  • Figure 6. Japan Immunoassay Market, By Product, 2024 & 2034 (USD Billion)
  • Figure 7. Market Technology
  • Figure 8. Japan Immunoassay Market, Technology, 2024 & 2034 (USD Billion)
  • Figure 9. Market By Specimen
  • Figure 10. Japan Immunoassay Market, By Specimen, 2024 & 2034 (USD Billion)
  • Figure 11. Market By Application
  • Figure 12. Japan Immunoassay Market, By Application, 2024 & 2034 (USD Billion)
  • Figure 13. Market by End Use
  • Figure 14. Japan Immunoassay Market, by End Use, 2024 & 2034 (USD Billion)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!